| NCT ID | NCT06129942 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Soochow University |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2026-05-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2021-09-01 with a primary completion date of 2026-05-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3. * All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period. Exclusion Criteria: * Using hypnotic or stimulating drugs. * Using antidepressants, except stable drugs maintained for more than three months; * Visual impairment, such as cataract, glaucoma, blindness, etc; * Cognitive impairment (MMSE \< 24); * There are uncontrollable hallucinations and mental diseases; * There are sleep phase delay / advance syndrome, shift work, jet lag, etc
Contact & Investigator
Chun-Feng Liu, PhD
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital of Soochow University
Frequently Asked Questions
Who can join the NCT06129942 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06129942 currently recruiting?
Yes, NCT06129942 is actively recruiting participants. Contact the research team at liuchunfeng@suda.edu.cn for enrollment information.
Where is the NCT06129942 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT06129942 clinical trial?
NCT06129942 is sponsored by Second Affiliated Hospital of Soochow University. The principal investigator is Chun-Feng Liu, PhD at Second Affiliated Hospital of Soochow University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.